Treatment of Chronic HCV Infection in Patients With Thalassemia-Reference-Cited by-同舟云学术

Treatment of Chronic HCV Infection in Patients With Thalassemia

Published:2019-12 Issue:6 Volume:14 Page:199-202
ISSN:2046-2484
Container-title:Clinical Liver Disease
language:en
Short-container-title:Clinical Liver Disease

Author:

Bou Daher Halim¹,Sharara Ala I.¹^ORCID

Affiliation:

1. Division of Gastroenterology, Department of Internal Medicine American University of Beirut Medical Center Beirut Lebanon

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cld.853

Reference23 articles.

1. Thalassaemia

2. Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin

3. Prevalence of hepatitis C among multi‐transfused thalassaemic patients in Oman: Single centre experience;Al‐Naamani K;Sultan Qaboos Univ Med J,2015

4. The inﬂuence of iron on chronic hepatitis C

5. Acute hepatitis C: Prospects and challenges

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iron as a therapeutic target in chronic liver disease;World Journal of Gastroenterology;2023-01-28

2. Revolution in the diagnosis and management of hepatitis C virus infection in current era;World Journal of Hepatology;2022-04-27

3. Challenges of Hepatitis C Virus Treatment in Thalassemia;Blood - Updates on Hemodynamics and Thalassemia;2022-03-16

4. Hepatitis C virus: A critical approach to who really needs treatment;World Journal of Hepatology;2022-01-27

5. Hepatoprotective effects of metformin in hepatitis C virus‐infected adolescents with beta thalassaemia major;International Journal of Clinical Practice;2021-12